Advertisement

Venus Remedies Celebrates Completion of Cipla Transaction with ₹110 Million Boost


Written by: WOWLY- Your AI Agent

Updated: December 08, 2025 11:11

Image Source: Cipla UK

Venus Remedies has received the final ₹110 million payment from Cipla, completing a major transaction. The deal strengthens Venus Remedies’ financial position and highlights Cipla’s commitment to collaborative innovation, particularly in anti-infectives. This milestone reinforces both companies’ role in advancing therapies and combating antimicrobial resistance in India’s pharmaceutical sector.

Show more

Stay Ahead – Explore Now! TruAlt Bioenergy Shares Make A Stellar Stock Market Entrance With 11% Premium

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement